Visions: Christine Durinx and Jérôme Van Biervliet, Managing Directors of VIB, Belgium Director Visions RESEARCH Visions: Christine Durinx and Jérôme Van Biervliet, Managing Directors of VIB, Belgium FEBS Communications May 28, 2024
Visions: Marta Miączyńska, Director of IIMCB, Poland Director Visions RESEARCH Visions: Marta Miączyńska, Director of IIMCB, Poland FEBS Communications Mar 20, 2024
Visions: Iannis Talianidis, Director of IMBB-FORTH, Greece Director Visions VIEWPOINTS Visions: Iannis Talianidis, Director of IMBB-FORTH, Greece FEBS Communications Mar 18, 2022
Visions: Ferenc Nagy, General Director of the Biological Research Centre, Szeged, Hungary Director Visions VIEWPOINTS Visions: Ferenc Nagy, General Director of the Biological Research Centre, Szeged, Hungary FEBS Communications Jan 26, 2022
Visions: Mike Stratton and the Wellcome Sanger Institute Director Visions VIEWPOINTS Visions: Mike Stratton and the Wellcome Sanger Institute FEBS Communications Jul 21, 2021
Visions: Matthias Wilmanns, Head of the European Molecular Biology Laboratory (EMBL) Hamburg Director Visions VIEWPOINTS Visions: Matthias Wilmanns, Head of the European Molecular Biology Laboratory (EMBL) Hamburg FEBS Communications Jun 25, 2021
Visions: Giulio Superti-Furga, Scientific Director, Research Center for Molecular Medicine (CeMM), Vienna, Austria Director Visions VIEWPOINTS Visions: Giulio Superti-Furga, Scientific Director, Research Center for Molecular Medicine (CeMM), Vienna, Austria FEBS Communications Jun 16, 2021
Visions: Alain Puisieux, Director of the Research Center of Institut Curie, Paris, France Director Visions Interdisciplinarity VIEWPOINTS Visions: Alain Puisieux, Director of the Research Center of Institut Curie, Paris, France FEBS Communications May 19, 2021
Visions: José M. Mato, Founder and General Director of the Centers for Cooperative Research in Biosciences (CIC bioGUNE) and in Biomaterials (CIC biomaGUNE), Spain Director Visions VIEWPOINTS Visions: José M. Mato, Founder and General Director of the Centers for Cooperative Research in Biosciences (CIC bioGUNE) and in Biomaterials (CIC biomaGUNE), Spain FEBS Communications May 10, 2021
Visions: Zlatko Trajanoski, Director of the Biocenter, Medical University of Innsbruck, Austria Director Visions Interdisciplinarity VIEWPOINTS Visions: Zlatko Trajanoski, Director of the Biocenter, Medical University of Innsbruck, Austria FEBS Communications Dec 01, 2020
Visions: Gregor Anderluh, Director of the National Institute of Chemistry in Ljubljana, Slovenia Director Visions VIEWPOINTS Visions: Gregor Anderluh, Director of the National Institute of Chemistry in Ljubljana, Slovenia FEBS Communications Mar 25, 2020
Visions: Juleen Zierath, Executive Director of the Novo Nordisk Foundation Center for Basic Metabolic Research, Denmark Director Visions VIEWPOINTS Visions: Juleen Zierath, Executive Director of the Novo Nordisk Foundation Center for Basic Metabolic Research, Denmark FEBS Communications Jan 06, 2020
Visions: Maria A. Blasco, Director of the Spanish National Cancer Research Centre, Spain Director Visions VIEWPOINTS Visions: Maria A. Blasco, Director of the Spanish National Cancer Research Centre, Spain FEBS Communications Sep 20, 2019
Visions: Michael Wakelam, Director of the Babraham Institute, UK Director Visions VIEWPOINTS Visions: Michael Wakelam, Director of the Babraham Institute, UK Michael Wakelam † Feb 19, 2019
Visions: Susan M. Gasser, Director of the Friedrich Miescher Institute for Biomedical Research, Switzerland Director Visions VIEWPOINTS Visions: Susan M. Gasser, Director of the Friedrich Miescher Institute for Biomedical Research, Switzerland FEBS Communications Mar 28, 2018
Visions: Josef Penninger, Scientific Director of the IMBA, Austria Director Visions VIEWPOINTS Visions: Josef Penninger, Scientific Director of the IMBA, Austria FEBS Communications Feb 07, 2018
The MRC Laboratory of Molecular Biology (LMB): looking back and shaping the future Director Visions VIEWPOINTS The MRC Laboratory of Molecular Biology (LMB): looking back and shaping the future Hugh Pelham Jan 09, 2018